932 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/584773/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-584773 Oct 25, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $8.03, moving -1.65% from the previous trading session.
Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? http://www.zacks.com/stock/news/583896/should-value-investors-buy-teva-pharmaceutical-industries-ltd-teva-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-583896 Oct 25, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teva's proposed opioid settlement could cost drugmaker pennies on the dollar https://www.cnbc.com/2019/10/24/tevas-proposed-opioid-settlement-could-cost-drugmaker-pennies-on-the-dollar.html Oct 24, 2019 - Teva Pharmaceutical's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review.
Here's Why Teva Pharmaceutical Soared Today https://www.fool.com/investing/2019/10/21/heres-why-teva-pharmaceutical-soared-today.aspx?source=iedfolrf0000001 Oct 21, 2019 - The company announced an unexpectedly favorable settlement in a lawsuit related to the opioid epidemic.
Teva settles Ohio opioid case for $45M in cash and Suboxone; shares up 17% https://seekingalpha.com/news/3507402-teva-settles-ohio-opioid-case-45m-cash-suboxone-shares-17-percent?source=feed_news_all Oct 21, 2019 - Teva Pharmaceutical Industries (TEVA +17.3%) has settled a lawsuit brought by two Ohio counties over its alleged role in the opioid epidemic there.Under the terms of the agreement, it has agreed to pa
Teva Pharmaceutical shares surge after announcing global opioid settlement https://www.cnbc.com/2019/10/21/teva-shares-surge-after-announcing-global-opioid-settlement.html Oct 21, 2019 - Under that deal, Teva would donate $23 billion in opioid addiction treatment drugs and pay $250 million over 10 years.
J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos http://www.zacks.com/stock/news/575752/jj-jnj-recalls-baby-powder-batch-as-fda-finds-asbestos?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-575752 Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
TEVA: Gabelli & Co ups to Buy https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191017082319 Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
Five companies said to be in talks over $22 billion opioid settlement https://www.cnbc.com/2019/10/16/five-companies-said-to-be-in-talks-over-22-billion-opioid-settlement.html Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810 Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.

Pages: 12345678910...94

<<<Page 5>